Cardiovascular Disease Cardiovascular Imaging Cholesterol 
Dr. Paddy Barrett
NOVEMBER 8, 2024
Only when you have a clear idea of those three factors can you decide whether or not to take a medication to lower your LDL cholesterol. I use statins in the question posed above because that is what most people think and, in fact, what they will start with when looking to lower their LDL cholesterol with a medication. Not zero risk.
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
DAIC
MARCH 31, 2025
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.
Dr. Paddy Barrett
FEBRUARY 27, 2024
‘Normal’ levels of risk factors such as blood pressure, cholesterol or blood glucose levels are often FAR from optimal. The Missing Variable Of Time One of the factors most often left out of cardiovascular risk discussions is the element of ‘cumulative time of exposure’ Risk is a function of two variables.
Circulation: Cardiovascular Imaging
FEBRUARY 4, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. Baseline arterial [18F]FDG uptake correlated with traditional cardiovascular risk factors, such as body mass index and male sex. Cross-sectional analyses suggested a negative effect of cholesterol-lowering medication on arterial [18F]FDG uptake at follow-up.
Expert insights. Personalized for you.
130 
Let's personalize your content